Accès à distance ? S'identifier sur le proxy UCLouvain
Concentration-controlled everolimus versus MMF in De Novo heart transplant patients: Incidence of CMV infection at 12 months post-transplant in a randomized trial
Primary tabs
| Document type | Communication à un colloque (Conference Paper) – Abstract, Présentation orale avec comité de sélection |
|---|---|
| Access type | Accès restreint |
| Publication date | 2008 |
| Language | Anglais |
| Conference | "28th Annual Meeting of the International-Society-for-Heart-and-Lung-Transplantation", Boston (Ma) (Apr 09-12, 2008) |
| Journal information | "The Journal of Heart and Lung Transplantation" - Vol. 27, no. 2, p. S65-S66 (2008) |
| Peer reviewed | yes |
| issn | 1053-2498 |
| e-issn | 1557-3117 |
| Publisher | Elsevier Science Inc (New York) |
| Affiliations |
UCL
- (SLuc) Département cardiovasculaire UCL - (SLuc) Service de chirurgie cardiovasculaire et thoracique |
| Links |
| Bibliographic reference | Dengler, T. ; Vigano, M. ; Magelli, C. ; Guillemain, R. ; Varnous, S. ; et. al. Concentration-controlled everolimus versus MMF in De Novo heart transplant patients: Incidence of CMV infection at 12 months post-transplant in a randomized trial.28th Annual Meeting of the International-Society-for-Heart-and-Lung-Transplantation (Boston (Ma), Apr 09-12, 2008). In: The Journal of Heart and Lung Transplantation, Vol. 27, no. 2, p. S65-S66 (2008) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/59475 |